Sign inJoin waitlistJoin the waitlist

RS

Rebecca Silbermann

Associate Professor of Medicine, Division of Hematology/Medical Oncology, School of Medicine · Oregon Health & Science University

Credentials: · · · · · ·

History

Oregon Health & Science University
Present

Hematology and Medical Oncology
UPMC
2008–2011
Internal Medicine
University of Rochester Medicine
2004–2007
Warren Alpert Medical School of Brown University
2000–2004

Research

Daratumumab, lenalidomide, bortezomib, and dexamethasone for transplant-eligible newly diagnosed multiple myeloma: the GRIFFIN trial
Blood · 2020 · 617 citations
Daratumumab, Carfilzomib, Lenalidomide, and Dexamethasone With Minimal Residual Disease Response-Adapted Therapy in Newly Diagnosed Multiple Myeloma
Journal of Clinical Oncology · 2022 · 224 citations
Enhanced gene silencing of HIV-1 specific siRNA using microRNA designed hairpins
Nucleic Acids Research · 2004 · 190 citations

Luciano Costa
21 papers
EM
Eva Medvedova
16 papers
Natalie Callander
14 papers
SB
Susan Bal
14 papers
Bhagirathbhai Dholaria
13 papers
Binod Dhakal
13 papers
Douglas Sborov
12 papers
Kelly Godby
12 papers
Peter Voorhees
11 papers
Saurabh Chhabra
11 papers
AC
Andrew Cowan
10 papers
David Roodman
10 papers

Clinical trials

Isatuximab, Carfilzomib, and Pomalidomide for the Treatment of Relapsed or Refractory Multiple Myeloma
Principal investigator · Active not recruiting · Phase 2
OHSU Knight Cancer Institute
2022–2029
A Phase IIa Study of Sotatercept on Bone Mass and Turnover in Patients With Multiple Myeloma
Principal investigator · Withdrawn · Phase 2
Rebecca Silbermann
2014–2016